<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>B502BSB25530</udiDi>
    <basicUdiDi>B-B502BSB25530</basicUdiDi>
    <tradeName>Tinto MUC-4, EP256, RMab</tradeName>
    <deviceName>Tinto MUC-4, EP256, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2553</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:30.889Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25520</udiDi>
    <basicUdiDi>B-B502BSB25520</basicUdiDi>
    <tradeName>Tinto MUC-4, EP256, RMab</tradeName>
    <deviceName>Tinto MUC-4, EP256, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2552</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:30.102Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25430</udiDi>
    <basicUdiDi>B-B502BSB25430</basicUdiDi>
    <tradeName>MMP-9, EP127, RMab</tradeName>
    <deviceName>MMP-9, EP127, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2543</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:28.506Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25420</udiDi>
    <basicUdiDi>B-B502BSB25420</basicUdiDi>
    <tradeName>MMP-9, EP127, RMab</tradeName>
    <deviceName>MMP-9, EP127, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2542</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:26.097Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25410</udiDi>
    <basicUdiDi>B-B502BSB25410</basicUdiDi>
    <tradeName>MMP-9, EP127, RMab</tradeName>
    <deviceName>MMP-9, EP127, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2541</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:24.501Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25400</udiDi>
    <basicUdiDi>B-B502BSB25400</basicUdiDi>
    <tradeName>Tinto MMP-9, EP127, RMab</tradeName>
    <deviceName>Tinto MMP-9, EP127, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2540</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:23.686Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25390</udiDi>
    <basicUdiDi>B-B502BSB25390</basicUdiDi>
    <tradeName>Tinto MMP-9, EP127, RMab</tradeName>
    <deviceName>Tinto MMP-9, EP127, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2539</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:22.086Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25380</udiDi>
    <basicUdiDi>B-B502BSB25380</basicUdiDi>
    <tradeName>Tinto MMP-9, EP127, RMab</tradeName>
    <deviceName>Tinto MMP-9, EP127, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2538</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:19.689Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25290</udiDi>
    <basicUdiDi>B-B502BSB25290</basicUdiDi>
    <tradeName>Histone H3 Phospho, EP233, RMab</tradeName>
    <deviceName>Histone H3 Phospho, EP233, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2529</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:18.085Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25280</udiDi>
    <basicUdiDi>B-B502BSB25280</basicUdiDi>
    <tradeName>Histone H3 Phospho, EP233, RMab</tradeName>
    <deviceName>Histone H3 Phospho, EP233, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2528</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:17.280Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25270</udiDi>
    <basicUdiDi>B-B502BSB25270</basicUdiDi>
    <tradeName>Histone H3 Phospho, EP233, RMab</tradeName>
    <deviceName>Histone H3 Phospho, EP233, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2527</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:15.679Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25250</udiDi>
    <basicUdiDi>B-B502BSB25250</basicUdiDi>
    <tradeName>Tinto Histone H3 Phospho, EP233, RMab</tradeName>
    <deviceName>Tinto Histone H3 Phospho, EP233, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2525</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:13.291Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25240</udiDi>
    <basicUdiDi>B-B502BSB25240</basicUdiDi>
    <tradeName>Tinto Histone H3 Phospho, EP233, RMab</tradeName>
    <deviceName>Tinto Histone H3 Phospho, EP233, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2524</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:11.675Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25220</udiDi>
    <basicUdiDi>B-B502BSB25220</basicUdiDi>
    <tradeName>HIF-1alpha, EP118, RMab</tradeName>
    <deviceName>HIF-1alpha, EP118, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2522</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:10.871Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25260</udiDi>
    <basicUdiDi>B-B502BSB25260</basicUdiDi>
    <tradeName>Tinto Histone H3 Phospho, EP233, RMab</tradeName>
    <deviceName>Tinto Histone H3 Phospho, EP233, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2526</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:04:09.275Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25210</udiDi>
    <basicUdiDi>B-B502BSB25210</basicUdiDi>
    <tradeName>HIF-1alpha, EP118, RMab</tradeName>
    <deviceName>HIF-1alpha, EP118, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2521</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:03:40.731Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25200</udiDi>
    <basicUdiDi>B-B502BSB25200</basicUdiDi>
    <tradeName>HIF-1alpha, EP118, RMab</tradeName>
    <deviceName>HIF-1alpha, EP118, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2520</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:03:39.932Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25190</udiDi>
    <basicUdiDi>B-B502BSB25190</basicUdiDi>
    <tradeName>Tinto HIF-1alpha, EP118, RMab</tradeName>
    <deviceName>Tinto HIF-1alpha, EP118, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2519</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:03:39.133Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25180</udiDi>
    <basicUdiDi>B-B502BSB25180</basicUdiDi>
    <tradeName>Tinto HIF-1alpha, EP118, RMab</tradeName>
    <deviceName>Tinto HIF-1alpha, EP118, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2518</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:03:38.330Z</lastUpdated>
  </row>
  <row>
    <udiDi>B502BSB25170</udiDi>
    <basicUdiDi>B-B502BSB25170</basicUdiDi>
    <tradeName>Tinto HIF-1alpha, EP118, RMab</tradeName>
    <deviceName>Tinto HIF-1alpha, EP118, RMab</deviceName>
    <manufacturerName>Bio SB Inc</manufacturerName>
    <manufacturerSrn>US-MF-000036462</manufacturerSrn>
    <authorisedRepresentativeName>QAdvis EAR AB</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>SE-AR-000001599</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BSB 2517</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-12T19:03:34.330Z</lastUpdated>
  </row>
</eudamedExport>